{"id":557722,"date":"2021-08-13T19:38:01","date_gmt":"2021-08-13T19:38:01","guid":{"rendered":"https:\/\/www.abnewswire.com\/pressreleases\/?p=557722"},"modified":"2021-08-13T19:38:01","modified_gmt":"2021-08-13T19:38:01","slug":"wide-ranging-benefits-of-vaccine-to-drive-global-vaccines-market-growth-reports-and-data","status":"publish","type":"post","link":"https:\/\/www.abnewswire.com\/pressreleases\/wide-ranging-benefits-of-vaccine-to-drive-global-vaccines-market-growth-reports-and-data_557722.html","title":{"rendered":"Wide Ranging Benefits of Vaccine to Drive Global Vaccines Market Growth – Reports and Data"},"content":{"rendered":"
\"Wide<\/a><\/div>\n
Increasing government funding for vaccine production and growing emphasis on immunization are major factors expected to drive the market<\/p>\n<\/div>\n

Few public health strategies can match the impact of immunizations. Vaccines have helped to minimize sickness, disability, and death caused by a wide range of infectious diseases. The World Health Organization suggests that immunization access must be expanded to meet the Sustainable Development Goals (SDGs). Vaccinations not only prevent illness and death from infectious diseases including diarrhoea, measles, pneumonia, polio, and whooping cough, but they also facilitate broader educational and economic progress. All of the diseases have been lowered by more than 90%, with several of them being eliminated or having reductions of 99 percent or higher. The vaccines market<\/a> continues to expand as inoculation proves to be the only way of keeping large portions of the population safe.<\/p>\n

According to a recent economic analysis of 10 vaccines for 94 low- and middle-income countries, a USD 34 billion investment in immunization programs saved USD 586 billion in reduced disease costs and USD 1.53 trillion when broader economic benefits were considered. Smallpox, the only human illness ever eradicated, was eradicated with the help of a vaccine, and polio is on the verge of eradication with the use of vaccines as well. Such factors have been fueling global vaccines market growth.<\/p>\n

Get a sample of the report @ <\/strong>https:\/\/www.reportsanddata.com\/sample-enquiry-form\/4023<\/a><\/p>\n

Millions of people worldwide have recently been infected with the COVID-19 disease. Community transmission has resulted in rising fatalities in some regions. In 2021, biopharmaceutical and biotech companies succeeded in bringing to market an effective vaccine against the virus that causes SARS-Cov-2. The coronavirus outbreak has sparked unprecedented demand and businesses are investing heavily in R&D activities along with government to meet the growing demand for COVID-19 vaccines. This is expected to boost the market’s growth prospects.<\/p>\n

Despite tremendous progress, various people around the world, including nearly 20 million babies last year, still lack access to vaccines. In some countries, progress has stalled or even reversed, and there is a real risk that complacency will undo previous achievements. Furthermore, high storage and transportation costs for vaccines can stifle market supply. These factors are expected to hamper the revenue growth of the vaccines market to a certain extent going ahead.<\/p>\n

Some Key Highlights in the Report:<\/p>\n

<\/strong><\/p>\n